0001214659-21-003204.txt : 20210316 0001214659-21-003204.hdr.sgml : 20210316 20210316202018 ACCESSION NUMBER: 0001214659-21-003204 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210312 FILED AS OF DATE: 20210316 DATE AS OF CHANGE: 20210316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cochran John CENTRAL INDEX KEY: 0001406773 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38599 FILM NUMBER: 21748017 MAIL ADDRESS: STREET 1: 201 MAIN STREET, SUITE 1900 CITY: FORT WORTH STATE: TX ZIP: 76102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aquestive Therapeutics, Inc. CENTRAL INDEX KEY: 0001398733 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208623253 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-941-1900 MAIL ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: MonoSol Rx, Inc. DATE OF NAME CHANGE: 20070507 4 1 marketforms-51914.xml PRIMARY DOCUMENT X0306 4 2021-03-12 0001398733 Aquestive Therapeutics, Inc. AQST 0001406773 Cochran John C/O AQUESTIVE THERAPEUTICS, INC. 30 TECHNOLOGY DRIVE WARREN NJ 07059 true false false false Common Stock 2021-03-12 4 J false 23038 0 A 98123 D Common Stock 2021-03-12 4 J false 8228 0 A 106351 D Common Stock 2021-03-12 4 J false 11544 0 A 117895 D Common Stock 2021-03-12 4 J false 19091 0 A 136986 D Pro rata distributions for no consideration of shares of common stock of the Issuer by the following entities, respectively (collectively, the "Distributing Entities"): MonoLine Rx, L.P., MonoLine Rx III, L.P., MonoSol Rx Genpar, L.P., and MRX Partners, LLC. The Reporting Person under this Form 4 possesses no voting or investment control over the securities held by the Distributing Entities. /s/ Robert Arnold, as Attorney-In-Fact 2021-03-16